Simeon George Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Simeon George.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Simeon George. Simeon George is Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and Director in Principia Biopharma Inc. ($PRNB) and Director in Turning Point Therapeutics, Inc. ($TPTX) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Nkarta, Inc. ($NKTX) and Director in Design Therapeutics, Inc. ($DSGN).
Latest Insider Trading Transactions of Simeon George
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRSP, DSGN, GNCA, NKTX, PRNB, TPTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2021 | NKTX | Nkarta, Inc. | George Simeon | Director | Option Exercise | A | 25.03 | 16,511 | 413,270 | 16,511 | |
| Jun 04 2021 | TPTX | Turning Point Ther ... | George Simeon | Director | Option Exercise | A | 65.64 | 8,500 | 557,940 | 8,500 | |
| Apr 01 2021 | DSGN | Design Therapeutic ... | George Simeon | Director | Option Exercise | C | 0.00 | 1,526,718 | 0 | 0 | |
| Apr 01 2021 | DSGN | Design Therapeutic ... | George Simeon | Director | Option Exercise | C | 0.00 | 7,236,938 | 0 | 0 | |
| Apr 01 2021 | DSGN | Design Therapeutic ... | George Simeon | Director | Buy | P | 20.00 | 250,000 | 5,000,000 | 5,626,476 | 5.4 M to 5.6 M (+4.65 %) |
| Apr 01 2021 | DSGN | Design Therapeutic ... | George Simeon | Director | Buy | C | 0.00 | 936,637 | 0 | 5,376,476 | 4.4 M to 5.4 M (+21.10 %) |
| Apr 01 2021 | DSGN | Design Therapeutic ... | George Simeon | Director | Buy | C | 0.00 | 4,439,839 | 0 | 4,439,839 | 0 to 4.4 M |
| Mar 29 2021 | DSGN | Design Therapeutic ... | George Simeon | Director | Option Exercise | A | 20.00 | 15,000 | 300,000 | 15,000 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | D | 31.77 | 10,240 | 325,325 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | D | 17.00 | 20,475 | 348,075 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | D | 8.99 | 28,623 | 257,410 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Sell | U | 100.00 | 2,982,855 | 298,285,500 | 0 | 3 M to 0 (-100.00 %) |
| Jul 13 2020 | NKTX | Nkarta, Inc. | George Simeon | Director | Option Exercise | A | 18.00 | 10,700 | 192,600 | 10,700 | |
| Jul 13 2020 | NKTX | Nkarta, Inc. | George Simeon | Director | Option Exercise | A | 18.00 | 10,700 | 192,600 | 10,700 | |
| Jun 17 2020 | TPTX | Turning Point Ther ... | George Simeon | Director | Option Exercise | A | 65.39 | 8,500 | 555,815 | 8,500 | |
| Jun 15 2020 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | A | 59.70 | 15,000 | 895,500 | 15,000 | |
| Jun 08 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | A | 62.66 | 10,240 | 641,638 | 10,240 | |
| May 26 2020 | TPTX | Turning Point Ther ... | George Simeon | Director | Buy | P | 60.00 | 83,333 | 4,999,980 | 2,253,660 | 2.2 M to 2.3 M (+3.84 %) |
| Oct 22 2019 | PRNB | Principia Biopharm ... | George Simeon | Director | Buy | P | 28.00 | 357,142 | 9,999,976 | 2,982,855 | 2.6 M to 3 M (+13.60 %) |
| Sep 11 2019 | TPTX | Turning Point Ther ... | George Simeon | Director | Buy | P | 45.00 | 177,777 | 7,999,965 | 2,170,327 | 2 M to 2.2 M (+8.92 %) |
| Jun 13 2019 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | A | 43.52 | 15,000 | 652,800 | 15,000 | |
| Jun 11 2019 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | A | 31.77 | 10,240 | 325,325 | 10,240 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | George Simeon | Director | Option Exercise | C | 0.00 | 2,105,259 | 0 | 0 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | George Simeon | Director | Option Exercise | C | 0.00 | 4,314,809 | 0 | 0 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | George Simeon | Director | Option Exercise | A | 27.06 | 15,000 | 405,900 | 15,000 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | George Simeon | Director | Buy | P | 18.00 | 325,000 | 5,850,000 | 1,992,550 | 1.7 M to 2 M (+19.49 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | George Simeon | Director | Buy | C | 0.00 | 546,820 | 0 | 1,667,550 | 1.1 M to 1.7 M (+48.79 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | George Simeon | Director | Buy | C | 0.00 | 1,120,730 | 0 | 1,120,730 | 0 to 1.1 M |
| Jan 10 2019 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | A | 17.00 | 20,475 | 348,075 | 20,475 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | C | 0.00 | 167,537 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | C | 0.00 | 544,047 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | C | 0.00 | 260,617 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | C | 0.00 | 312,741 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | C | 0.00 | 1,070,771 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Buy | P | 17.00 | 270,000 | 4,590,000 | 2,625,713 | 2.4 M to 2.6 M (+11.46 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Buy | C | 0.00 | 167,537 | 0 | 2,355,713 | 2.2 M to 2.4 M (+7.66 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Buy | C | 0.00 | 544,047 | 0 | 2,188,176 | 1.6 M to 2.2 M (+33.09 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Buy | C | 0.00 | 260,617 | 0 | 1,644,129 | 1.4 M to 1.6 M (+18.84 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Buy | C | 0.00 | 312,741 | 0 | 1,383,512 | 1.1 M to 1.4 M (+29.21 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Buy | C | 0.00 | 1,070,771 | 0 | 1,070,771 | 0 to 1.1 M |
| Jun 19 2018 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | A | 59.31 | 15,000 | 889,650 | 15,000 | |
| Jun 02 2017 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | A | 13.62 | 15,000 | 204,300 | 15,000 | |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | C | 0.00 | 211,567 | 0 | 0 | |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | C | 0.00 | 2,942,560 | 0 | 0 | |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Buy | P | 14.00 | 66,500 | 931,000 | 3,220,627 | 3.2 M to 3.2 M (+2.11 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Buy | C | 0.00 | 211,567 | 0 | 3,154,127 | 2.9 M to 3.2 M (+7.19 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Buy | C | 0.00 | 2,942,560 | 0 | 2,942,560 | 0 to 2.9 M |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | A | 14.00 | 30,000 | 420,000 | 30,000 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Option Exercise | C | 0.00 | 4,851,958 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Option Exercise | C | 0.00 | 4,099,231 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Option Exercise | C | 0.00 | 9,230,769 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Buy | C | 0.00 | 407,727 | 0 | 1,671,667 | 1.3 M to 1.7 M (+32.26 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Buy | C | 0.00 | 344,473 | 0 | 1,263,940 | 919.5 K to 1.3 M (+37.46 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Buy | C | 0.00 | 775,694 | 0 | 919,467 | 143.8 K to 919.5 K (+539.53 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Buy | P | 12.00 | 143,773 | 1,725,276 | 143,773 | 0 to 143.8 K |
Page: 1